Publicacions científiques

Article

Editors' note: Patient-reported outcomes across cerebrovascular event types: More similar than different

Autor/s:

Lewis A, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 93 n. 20

http://n.neurology.org/content/93/20/905.1.extract

Editors' note: Pattern of polyphenol intake and the long-term risk of dementia in older persons

Autor/s:

Ganesh A, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 92 n. 10

http://n.neurology.org/content/92/10/493.1.extract

Article

Editors' note: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis

Autor/s:

Ganesh A, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 93 n. 4

http://n.neurology.org/content/93/4/182.2.extract

Article

Editors' note: Postconvulsive central apnea as a biomarker for sudden unexpected death in epilepsy (SUDEP)

Autor/s:

Lewis A, Galetta S

Any publicació:

2019

Número de revista:

Neurology vol. 93 n. 23

http://n.neurology.org/content/93/23/1020.1.extract

Editors' note: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Autor/s:

Lewis A, Galetta S.

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 92 n. 2

http://n.neurology.org/content/92/2/109.1.extract

Article

Editors' note: Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation

Autor/s:

Siegler III JE, Steven Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 92 n. 24

http://n.neurology.org/content/92/24/1163.1.extract

Editors' note: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Autor/s:

Siegler III JE, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 92 n. 12

http://n.neurology.org/content/92/12/585.1.extract

Article

Editors' note: Residency Training: Enhancing resiliency in our residents: Combining the principles of business and neurobiology

Autor/s:

Lewis A, Galetta S.

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 93 n. 5

http://n.neurology.org/content/93/5/228.3.extract

Editors' note: Right Brain: Withholding treatment from a child with an epileptic encephalomyopathy.

Autor/s:

Ganesh A, Galetta S. ...

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 92 n. 1

http://n.neurology.org/content/92/1/55.1.extract

Article

Editors' note: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial

Autor/s:

Ganesh A, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2019

Número de revista:

Neurology vol. 93 n. 7

http://n.neurology.org/content/93/7/319.1.extract

Una iniciativa de:

Cercador

Editors' note: Patient-reported outcomes across cerebrovascular event types: More similar than different

Editors' note: Pattern of polyphenol intake and the long-term risk of dementia in older persons

Editors' note: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis

Editors' note: Postconvulsive central apnea as a biomarker for sudden unexpected death in epilepsy (SUDEP)

Editors' note: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Editors' note: Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation

Editors' note: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Editors' note: Residency Training: Enhancing resiliency in our residents: Combining the principles of business and neurobiology

Editors' note: Right Brain: Withholding treatment from a child with an epileptic encephalomyopathy.

Editors' note: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!